In antitumor immunotherapy, natural killer cells can induce macrophages to polarize toward inflammatory M1 type for tumor targeting via proteins in natural killer cell membranes, such as RANKL or DNAM‐1.[241] Therefore, the 2D‐NBPFs modified by natural killer all membranes may have better tumor treatment effects. This evidence concerns the gene CD226 and neoplasm.